Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2002
12/12/2002WO2002098351A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
12/12/2002WO2002098287A2 A high throughput biological heart rate monitor that is molecularly determined
12/12/2002WO2002098286A2 Implantation of biological pacemaker that is molecularly determined
12/12/2002WO2002083891A3 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
12/12/2002WO2002076508B1 Methods for delivering nucleic acid molecules into cells and assessment thereof
12/12/2002WO2002076494A3 USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
12/12/2002WO2002070552A3 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
12/12/2002WO2002065989A3 Aminoglycoside treatment for lysosomal storage diseases
12/12/2002WO2002064161A3 Method and compositions for immunization with the pseudomonas v antigen
12/12/2002WO2002061113A3 Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation
12/12/2002WO2002050106A3 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4
12/12/2002WO2002038188A3 Use of the human lrp/mvp promotor for a vector that can be induced by therapy
12/12/2002WO2002036774A3 Derivatives of the human macrophage-migration inhibition factor (mif) and use thereof in pharmaceutical preparations in screening methods or the identification of analogues, agonists and antagonists
12/12/2002WO2002029044A3 Modulation of the transcription of pro-inflammatory gene products
12/12/2002WO2002026957A3 Regulation of a human serine protease
12/12/2002WO2002026941A3 Primitive neural stem cells and method for differentiation of stem cells to neural cells
12/12/2002WO2002024899A3 Improved system for regulation of transgene expression
12/12/2002WO2002018593A3 Modulation of fas and fasl expression
12/12/2002WO2002018439A3 52991, a human transporter protein and uses therefor
12/12/2002WO2002002775A3 Calpain protease 12
12/12/2002WO2001089568A9 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
12/12/2002WO2001047942A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
12/12/2002WO2001027303A9 Adeno-associated virus vectors encoding factor viii and methods of using the same
12/12/2002WO2001018207A9 Human 7tm proteins receptors and polynucleotides encoding the same
12/12/2002US20020188212 High throughput biological heart rate monitor that is molecularly determined
12/12/2002US20020188110 Transforming growth factor alpha HI
12/12/2002US20020188023 Compound
12/12/2002US20020187972 Methods for modulating expression of exogenous genes in mammalian systems
12/12/2002US20020187955 Method of inducing angiogenesis in nonischemic skeletal muscle
12/12/2002US20020187954 Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth
12/12/2002US20020187953 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation
12/12/2002US20020187951 Lentiviral-mediated growth factor gene therapy for neurodegenerative diseases
12/12/2002US20020187949 High throughput biological heart rate monitor that is molecularly determined
12/12/2002US20020187948 Implantation of biological pacemaker that is molecularly determined
12/12/2002US20020187947 Inflammation-related gene
12/12/2002US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002US20020187936 Methods of treating liver disease and liver damage with growth hormone and foxM1B
12/12/2002US20020187931 Modulating cell survival by modulating huntingtin function
12/12/2002US20020187930 Substances and their uses
12/12/2002US20020187922 Novel molecules of the pyrin domain protein family and uses thereof
12/12/2002US20020187553 Packaging systems for human recombinant adenovirus to be used in gene therapy
12/12/2002US20020187543 Enhanced dispersion of adenoviral vectors by fusogenic membrane glycoproteins
12/12/2002US20020187527 Generation of nucleotide sequence which can be used as tools of gene therapy; obtain cells, transform with expression vector, recover transformed cells, detect methyltransferase expression and methylated nucleotide sequences
12/12/2002US20020187499 Kit for use in monitoring and treatment of endometriosis
12/12/2002US20020187482 Methods and means of RNA analysis
12/12/2002US20020187473 Polyamide nucleic acid derivatives, and agents and processes for preparing them
12/12/2002US20020187472 Nucleotide sequences coding protein for use in the treatment of cancer
12/12/2002US20020187471 Novel telomerase
12/12/2002US20020187163 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine
12/12/2002US20020187157 Administering an amyloidogenic polypeptide or subsequence thereof to induces production of antibodies against the amyloidogenic polypeptide; treatment of Alzheimer's disease
12/12/2002US20020187149 Activity-inhibiting amount of a growth factor neutralising agent or agents specific against only fibrotic growth factors together with a pharmaceutically acceptible carrier.
12/12/2002US20020187143 Methods and compositions for reducing immune response
12/12/2002US20020187142 Crosslinking of these receptors with a bispecific molecule of the invention would lead to inhibition of the release of allergic mediators and amelioration of the symptoms of allergic diseases.
12/12/2002US20020187132 Cardiac gene transfer
12/12/2002US20020187129 Adeno-associated virus materials and methods
12/12/2002US20020187128 Novel replication deficient adenovirus vectors and methods for making and using them
12/12/2002US20020187127 Methods of increasing distribution of nucleic acids
12/12/2002US20020187126 Using modified herpes simplex virus (HSV) having a defect in ICP27 (HSV Delta 27), wherein the cancer cell is resistant to anti-cancer therapy.
12/12/2002US20020187105 Polymer combinations that result in stabilized aerosols for gene delivery to the lungs
12/12/2002DE10125893A1 Medicament used for inhibiting vascular smooth muscle cell growth, especially for combating cardiovascular disease, contains gut enriched Kruppel-like factor related nucleotide sequence or corresponding polypeptide
12/12/2002CA2830887A1 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
12/12/2002CA2457959A1 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
12/12/2002CA2449940A1 Bcl-2 dnazymes
12/12/2002CA2449837A1 Implantation of biological pacemaker that is molecularly determined
12/12/2002CA2449770A1 Novel anti-infectives
12/12/2002CA2449658A1 Use of rank antagonists to treat cancer
12/12/2002CA2449482A1 Chds as modifiers of the p53 pathway and methods of use
12/12/2002CA2449425A1 Slc2as as modifiers of the p53 pathway and methods of use
12/12/2002CA2449289A1 Gfats as modifiers of the p53 pathway and methods of use
12/12/2002CA2449281A1 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002CA2449275A1 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002CA2449270A1 Pibs as modifiers of the p53 pathway and methods of use
12/12/2002CA2449267A1 Hs2sts as modifiers of the p53 pathway and methods of use
12/12/2002CA2449221A1 P5crs as modifiers of the p53 pathway and methods of use
12/12/2002CA2449206A1 Cads as modifiers of the p53 pathway and methods of use
12/12/2002CA2449136A1 Igs as modifiers of the p53 pathway and methods of use
12/12/2002CA2449008A1 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
12/12/2002CA2448828A1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
12/12/2002CA2448824A1 Novel compounds for chemiluminescense procedures
12/12/2002CA2448444A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/12/2002CA2448384A1 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
12/12/2002CA2448382A1 Use of hepcidin as a regulator of iron homeostasis
12/12/2002CA2448282A1 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002CA2448256A1 Novel human proteins, polynucleotides encoding them and methods of using the same
12/12/2002CA2448250A1 Limks as modifiers of the p53 pathway and methods of use
12/12/2002CA2448107A1 Marks as modifiers of the p53 pathway and methods of use
12/12/2002CA2448073A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/12/2002CA2448066A1 Chimeric alphavirus replicon particles
12/12/2002CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002CA2418088A1 Numb protein expression inhibitors by musashi 1
12/11/2002EP1264892A2 Lentiviral vectors comprising endothelial cell specific promoters
12/11/2002EP1264889A1 Chicken leukemia inhibitory factor (LIF) and the gene thereof
12/11/2002EP1264884A1 Method of controlling telomere length
12/11/2002EP1263965A2 Avirulent, immunogenic flavivirus chimeras
12/11/2002EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
12/11/2002EP1263955A2 Polypeptides and nucleic acids encoding same
12/11/2002EP1263954A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/11/2002EP1263944A2 Nucleic acids, proteins, and antibodies
12/11/2002EP1263943A1 Protein c derivatives
12/11/2002EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
1 ... 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 ... 870